MedPath

Effect of a group-based lifestyle intervention on risk factors and insulin resistance for metabolic syndrome

Not Applicable
Conditions
Metabolic syndrome
Registration Number
JPRN-UMIN000002342
Lead Sponsor
Metabolic medicine, Faculty of medical and pharmaceutical sciences, Kumamoto University.
Brief Summary

After 10 months, Standard(S) and Intensive(I) intervention showed improvements of BMI , HDL-C, FBS, A1c and mean number of components of MS. Further after 2 years, sustained effect on BMI was observed in S and I. No change in mean number of components of MS from baseline in S and I and a significant increase in that of Control group were observed. An insulin sensitivity index and a hepatic insulin resistance index were improved after intervention. The improvements of components of MS were correlated with the increase in WBISI.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

The subjects who take medication for hypertension, dyslipidemia and diabetes.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of components of MS and insulin sensitivity after 10 months and further after 2 years of intervention.
Secondary Outcome Measures
NameTimeMethod
The effect of BMI, blood pressure, lipid, blood glucose after 10 months and further after 2 years of intervention.
© Copyright 2025. All Rights Reserved by MedPath